Pharmena S.A. Capital Reinvestment Ratio

Latest as of June 2023: 0.00x

Pharmena S.A. capital reinvestment ratio. Pharmena S.A. (PHR) has a Capital Reinvestment Ratio of 0.00x as of June 2023, meaning it reinvests 0% of its operating cash flow (zł44.83 Million) in capital expenditures (zł131.00K). Check PHR cash reinvestment to operating cash ratio to assess the company's total reinvestment commitment from operating cash flow.

Capital Reinvestment Ratio

0.00x
Capex / Operating Cash Flow

Operating Cash Flow

zł44.83 Million
PLN

Capital Expenditures

zł131.00K
PLN

Data as of

Jun 2023
Most recent filing

Capital Reinvestment Ratio of Pharmena S.A. (2011–2023)

Capital reinvestment ratio of Pharmena S.A. from 2011 to 2023. This chart tracks Pharmena S.A.'s Capital Reinvestment Ratio across 5 annual periods. Also explore net asset growth rate of Pharmena S.A. to track the company's year-over-year net asset growth rate.

Pharmena S.A. Capital Reinvestment Ratio by Year (2011–2023)

Pharmena S.A. capital reinvestment ratio by year from 2011 to 2023. For the full cash flow conversion analysis, see PHR operating cash flow.

Year Reinvestment Ratio Operating CF (PLN) Capital Expenditures YoY Change
2023 0.01x zł33.03 Million zł314.00K ▼ -92.3%
2022 0.12x zł1.82 Million zł226.00K ▲ +0.6%
2018 0.12x zł3.61 Million zł446.00K ▼ -61.2%
2017 0.32x zł619.00K zł197.00K ▲ +208.1%
2011 0.10x zł666.91K zł68.89K —
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow